Market
Wellinks secures $10m for respiratory disease RPM tool’s advancement
Wellinks raised $10 million in Series B funding to advance its remote patient monitoring platform for respiratory disease management. The round included participation from UMass Memorial Health, building on an existing relationship. The funding will support continued development of the RPM tool for chronic respiratory conditions.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network